. 2007 Jul 3;81(18):9693–9706. doi: 10.1128/JVI.00492-07

TABLE 2.

Percentage of cell subsets in total PBMC

Group	Patient	% in PBMC of:
		CD4⁺ T cells in first sampling set			Total CD4⁺ T cells in second sampling set	CD4⁻/CD8⁻ CD3⁺ cells in second sampling set^a	Monocytes (CD14⁺) in first sampling set
		Total	CD25⁻, CD69⁻, HLA-DR⁻	CD25⁺, CD69⁺, HLA-DR⁺	Total CD4⁺ T cells in second sampling set	CD4⁻/CD8⁻ CD3⁺ cells in second sampling set^a	Monocytes (CD14⁺) in first sampling set
A	03	30	15	15			8
	04	13	8	5	10	12	10
	07	23	6	16	27	3	19
	08	26	13	13		2	18
	13	19	10	9	32	3	26
	14	24	8	16	22	3	19
Median		23	9	14	25	3	19
B	05	24	12	12	20	7	18
	06	26	17	9	19	17	12
	10	28	17	11	22	4	13
	11	11	5	6			20
	15	13	5	8	15	6	21
	16	26	14	12	34	10	22
Median		25	13	10	20	7	19

αβ TCR⁺ CD4⁻/CD8⁻ T cells were assumed to represent 50% of total CD4⁻/CD8⁻ T cells (45).